tiprankstipranks
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
US Market
BLCO
Bausch + Lomb Corporation
RESEARCH TOOLSreports

Bausch + Lomb Corporation (BLCO) Stock News & Sentiment

151 Followers
Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call
Premium
Company Announcements
Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call
1d ago
BLCO
Bausch + Lomb’s ELIOS Glaucoma System Hits Key Efficacy Marks in 24‑Month U.S. Trial
Premium
Company Announcements
Bausch + Lomb’s ELIOS Glaucoma System Hits Key Efficacy Marks in 24‑Month U.S. Trial
8d ago
BLCO
Bausch + Lomb Launches R&D Webinar Series Spotlighting Glaucoma Pipeline
Premium
Company Announcements
Bausch + Lomb Launches R&D Webinar Series Spotlighting Glaucoma Pipeline
22d ago
BLCO
Bausch + Lomb Leverages New Global Review to Spotlight LUMIFY’s Edge in Rising Ocular Redness Market
Premium
Company Announcements
Bausch + Lomb Leverages New Global Review to Spotlight LUMIFY’s Edge in Rising Ocular Redness Market
1M ago
BLCO
Maintaining Sell: Structural Overhangs and Margin Shortfalls Overshadow Bausch + Lomb’s Growth Story
Premium
Ratings
Maintaining Sell: Structural Overhangs and Margin Shortfalls Overshadow Bausch + Lomb’s Growth Story
1M ago
BLCO
Bausch + Lomb Signals Profitable Growth After Record Year
Premium
Company Announcements
Bausch + Lomb Signals Profitable Growth After Record Year
1M ago
BLCO
Bausch + Lomb Lifts 2025 Revenue on Dry Eye and Vision Care Growth
Premium
Company Announcements
Bausch + Lomb Lifts 2025 Revenue on Dry Eye and Vision Care Growth
1M ago
BLCO
More BLCO News >

BLCO News on the Web

Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call
TipRanks News
Neutral
A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story
The Motley Fool
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Lifecore Biomedical (LFCR), Pyxis Oncology (PYXS) and Bausch + Lomb Corporation (BLCO)
TipRanks News
Neutral
Bausch + Lomb (BLCO) Achieves Key Milestones with ELIOS System for Glaucoma
GuruFocus News
Bullish
Bausch + Lomb’s ELIOS Glaucoma System Hits Key Efficacy Marks in 24‑Month U.S. Trial
TipRanks News
Neutral
Why Bausch + Lomb Shares Are Sliding Despite Good News
TipRanks News
Neutral
Bausch + Lomb announces 24-month U.S. data on ELIOS system in Glaucoma
TipRanks News
Bullish
Eye Care Giant Posts $5.1 Billion in Revenue as One Investor Builds Major Position
The Motley Fool
Bullish

News Score - Last 7 Days

Neutral
BLCO
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week50%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BLCO’s Media Buzz Sentiment?
1 articles about BLCO were published this week. In an average week, 3.5 articles are published.
    What is BLCO’s weekly average amount of articles?
    In an average week, 3.5 articles about BLCO are published.
      What is BLCO’s News Sentiment?
      50% of articles about BLCO were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        0QAVNanobiotix
        PALIPalisade Bio
        DBVTDBV Technologies SA - American
        640China Resources Pharmaceutical Group Ltd.
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week